Major Portfolio Companies
Life Sciences, Consumer & Real Estate
Back to previous data
View more data
|
|
Market
Capitalisation
or Shareholder Equity1 |
|
Key
figures2 |
|
|
|
|
|
|
Revenue |
|
PATMI |
|
Shareholding (%)
as at 31 Mar 10 |
Currency |
2009 |
2010 |
|
FY 2008 |
FY 2009 |
|
FY 2008 |
FY 2009 |
 |
14 |
SGD'm |
2,501 |
5,230 |
|
8,112 |
8,588 |
|
168 |
252 |
 |
15 |
SGD'm |
3,516 |
6,706 |
|
4,990* |
5,333 |
|
436 |
360 |
 |
39 |
SGD'm |
9,889 |
16,901 |
|
2,752 |
2,957 |
|
1,260 |
1,053 |
 |
4 |
HKD'm |
66,148 |
144,634 |
|
110,722 |
104,479 |
|
2,422 |
3,369 |
 |
100 |
SGD'm |
4,671 |
5,095 |
|
445 |
453 |
|
210 |
394 |
 |
44 |
SGD'm |
1,306 |
2,897 |
|
1,062 |
1,539 |
|
147 |
181 |
 |
88 |
SGD'm |
131 |
148 |
|
87 |
91 |
|
17 |
17 |
|
|
Key figures2 |
|
TSR3 (%) |
|
|
EVA |
|
Change in EVA |
|
Years |
|
|
FY 2008 |
FY 2009 |
|
FY 2008 |
FY 2009 |
|
1 |
3 |
5 |
 |
|
NA |
106 |
|
NA |
NA |
|
81.2 |
(2.9) |
30.3 |
 |
|
(251)* |
(357) |
|
(208)* |
(106) |
|
95.9 |
1.2 |
13.2 |
 |
|
(511) |
(568) |
|
(459) |
(57) |
|
73.5 |
(14.1) |
18.2 |
 |
|
883* |
1,091 |
|
NA |
208 |
|
115.0 |
18.8 |
27.9 |
 |
|
(499) |
284 |
|
(1,392) |
783 |
|
9.4 |
14.4 |
18.4 |
 |
|
NA |
67 |
|
NA |
NA |
|
129.7 |
4.9 |
10.6 |
 |
|
5 |
5 |
|
(3) |
– |
|
13.0 |
15.8 |
17.9 |
Footnotes:
Back to top